Skip to main content
Clinical Trials/KCT0008661
KCT0008661
Not yet recruiting
未知

A Phase III Randomized Clinical Trial of Laparoscopic or Robotic RH using cancer cell spillage minimizing techniques vs Abdominal RH in Patients with Early-Stage Cervical Cancer

Asan Medical Center0 sites452 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Asan Medical Center
Enrollment
452
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients aged 20\-80 years
  • 2\) Histologically confirmed adenocarcinoma, squamous cell carcinoma, or adenosquamous cell carcinoma of the cervix
  • 3\) Patients who qualify for 2018 FIGO IA2 or IB1\-2
  • 4\) Patients undergoing type II or III radical hysterectomy (Piver Classification)
  • 5\) Patients with adequate bone marrow, kidney and liver function
  • ? WBC \= 3,000/mm3
  • ? Platelets \= 100,000/mm3
  • ? Creatinine \= 2\.0 mg/dL
  • ? Bilirubin \= 1\.5 x institutional upper limit normal
  • ? SGOT, SGPT, and ALP \= 3 x institutional upper limit normal

Exclusion Criteria

  • 1\) Any histological type other than adenocarcinoma, squamous cell carcinoma or adenosquamous cell carcinoma of the cervix
  • 2\) Tumor size greater than 4 cm on imaging examination
  • 3\) FIGO stage II\-IV
  • 4\) Patients with a history of pelvic or abdominal radiation therapy
  • 5\) Patients with evidence of metastatic disease on preoperative imaging, enlarged pelvic or aortic lymph nodes \> 1\.5 cm; or histologically positive lymph nodes
  • 6\) If you are unable to determine whether to consent yourself
  • 7\) Patients with serious underlying diseases or complications
  • 8\) Women who are pregnant or lactating
  • 9\) Neoadjuvant chemotherapy or preoperative radiation therapy
  • 10\) Patients who have had cancer other than non\-melanoma skin cancer, cervical intraepithelial tumor, and superficial cancer of the stomach and bladder within 5 years or have received cancer treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials